MMP9 and synovial sarcoma: The biomarkers S100A6, MMP-9 and CST4 were analyzed in 32 tear samples collected from CTs (n = 10) and SS patients (n = 22) using an AbMA (Table 1, Figure 2), and Cliff’s delta values were calculated to quantify the difference between the control and pathological groups.